Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples

We previously demonstrated that amplified in breast cancer 1 (AIB1) and eukaryotic initiation factor 2 (EIF5A2) overexpression was an independent predictor of poor clinical outcomes for patients with bladder cancer (BCa). In this study, we evaluated the usefulness of AIB1 and EIF5A2 alone and in com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhou, Bang-Fen, Wei, Jin-Huan, Chen, Zhen-Hua, Dong, Pei, Lai, Ying-Rong, Fang, Yong, Jiang, Hui-Ming, Lu, Jun, Zhou, Fang-Jian, Xie, Dan, Luo, Jun-Hang, Chen, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173089/
https://ncbi.nlm.nih.gov/pubmed/27203388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados